Tepezza

Tepezza Warnings and Precautions

• Infusion reactions: Can occur during or within 1.5 hours after infusion, including high blood pressure, rapid heartbeat, flushing, and difficulty breathing.
• Hyperglycemia: Blood glucose should be assessed before each infusion and monitored throughout treatment, especially in patients with pre-existing diabetes.
• Inflammatory bowel disease (IBD): Tepezza may cause new-onset IBD or worsen existing IBD; patients should be monitored, and treatment discontinued if IBD exacerbation is suspected.
• Hearing impairment: Hearing loss or other hearing changes have been reported, sometimes persisting after treatment; hearing should be assessed before and during treatment.
• Embryo-fetal toxicity: Tepezza can cause fetal harm. Effective contraception is recommended during treatment and for a period after the last dose.

How to Access Tepezza in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant, cold-chain conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Tepezza to India?

Tepezza (teprotumumab-trbw) injection may be imported in the patient's name only, by patients or government hospitals, in line with India's import regulations for unapproved medicines. The following documentation is required:

• A valid prescription from a qualified endocrinologist or ophthalmologist
• The patient's diagnostic reports confirming thyroid eye disease
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.

Is Tepezza available in India?

Tepezza (teprotumumab-trbw injection) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Tepezza is not commercially marketed in India.

However, patients in India can legally access Tepezza through the Named Patient Program (NPP) — an import provision that allows patients to receive medicines approved in other countries but not yet marketed in India, under a doctor's prescription and proper regulatory documentation.

Tepezza received US FDA approval in 2020 for the treatment of thyroid eye disease, ensuring full transparency throughout the process.

Tepezza can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others.

Sourcing & Delivery of Tepezza

Tepezza is sourced directly from authorized channels in the country of origin and shipped to India under GDP-compliant, cold-chain logistics to preserve product integrity from dispatch to delivery.

• Cold-chain shipping maintained at 2°C to 8°C throughout transit
• Real-time shipment tracking and delivery updates
• Delivery coordinated directly with the patient, family, or treating hospital

Availability of Tepezza Across Major Cities in India

Named Patient Program supports access to Tepezza for patients with thyroid eye disease across major cities in India, coordinating documentation, sourcing, and delivery with treating specialists.

Mumbai

Patients in Mumbai can access Tepezza through NPP with support from treating endocrinologists and ophthalmologists at the city's leading centers.

Delhi

In Delhi, NPP coordinates with hospitals and specialty endocrinology and eye care clinics to facilitate timely access to Tepezza.

Bangalore

Bangalore's endocrinology and ophthalmology centers work with NPP to support patients requiring Tepezza.

Chennai

Patients in Chennai can access Tepezza through NPP, with coordination between treating doctors and the program's regulatory and logistics team.

Hyderabad

Hyderabad's endocrinology and eye care centers support diagnosis and access coordination for Tepezza through NPP.

Kolkata

NPP facilitates access to Tepezza for patients in Kolkata under the guidance of treating specialists.

Pune

Patients in Pune can access Tepezza through NPP with prescription-based coordination and cold-chain delivery support.

Ahmedabad

NPP supports access to Tepezza for patients in Ahmedabad, working directly with treating specialists.

Kochi

Patients in Kochi and across Kerala can access Tepezza through NPP's regulated import pathway.

Chandigarh

NPP coordinates access to Tepezza for patients in Chandigarh and the surrounding region.

Jaipur

Patients in Jaipur can access Tepezza through NPP with support from treating specialists.

Lucknow

NPP facilitates access to Tepezza for patients in Lucknow and across Uttar Pradesh.

Bhubaneswar

Patients in Bhubaneswar can access Tepezza through NPP's coordinated import and delivery process.

Guwahati

NPP supports access to Tepezza for patients in Guwahati and across the Northeast region.

NPP also supports access for patients in other Indian cities not listed above — contact the team to check availability and timelines for your location.